Stepping Into the Era of Combination Cancer Therapies, Part 2: Combining Targeted Therapies

"Philadelphia, PA - The AACR 2015 Annual Meeting - Ursala Matulonis discusses her research during the AACR Press Conference at the American Association for Cancer Research Annual Meeting here today, Tuesday April 21, 2015. More than 18,000 physicians, researchers, health care professionals, cancer survivors and patient advocates are expected to attend the meeting at the Pennsylvania Convention Center. The Annual Meeting highlights the latest findings in all major areas of cancer research from basic through clinical and epidemiological studies. Photo by © AACR/Todd Buchanan 2015 Contact Info: Keywords: 15AACR_Meet the Editors: Cancer Discovery session"

In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015 that hold promise for combination cancer therapies, I discussed clinical trials …

Read More

Cancer Research Catalyst’s 10 Most-read Blog Posts of 2014

sparkler and colorful bokeh

Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground, from breast cancer prevention to new FDA approvals; and from groundbreaking immunotherapies to that old medicine cabinet standby, aspirin.

Read More

SABCS 2014: Immunotherapy Shows Early Promise for Triple-negative Breast Cancer Patients


After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope for women with a very challenging form of breast cancer—triple-negative breast …

Read More